Around the Net

Pfizer to Halt Advertising of Celebrex to Consumers

Pfizer said yesterday that it would immediately stop advertising Celebrex, its best-selling arthritis pain reliever, to consumers after a study showed that high doses were associated with an increased risk of heart attacks.

Read the whole story at The New York Times, December 20, 2004 »

Next story loading loading..